Lululemon Athletica (LULU) Financials

$270.77 -0.50 (-0.18%)

As of 04:00 PM Eastern

Annual Income Statements for Lululemon Athletica

This table shows Lululemon Athletica's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Income / (Loss) Attributable to Common Shareholders	266	303	259	484	646	589	957	798	1,539	1,654
Consolidated Net Income / (Loss)	266	303	259	484	646	589	975	855	1,550	1,815
Net Income / (Loss) Continuing Operations	266	303	259	484	646	589	975	855	1,550	1,815
Total Pre-Tax Income	368	423	460	715	897	819	1,334	1,333	2,176	2,576
Total Operating Income	369	421	456	706	889	820	1,333	1,328	2,133	2,506
Total Gross Profit	997	1,200	1,399	1,816	2,223	2,464	3,609	4,492	5,609	6,271
Total Revenue	2,061	2,344	2,649	3,288	3,979	4,402	6,257	8,111	9,619	10,588
Operating Revenue	2,061	2,344	2,649	3,288	3,979	4,402	6,257	8,111	9,619	10,588
Total Cost of Revenue	1,063	1,145	1,250	1,472	1,756	1,938	2,648	3,618	4,010	4,317
Operating Cost of Revenue	1,063	1,145	1,250	1,472	1,756	1,938	2,648	3,618	4,010	4,317
Total Operating Expenses	628	778	943	1,110	1,334	1,644	2,275	3,164	3,477	3,765
Selling, General & Admin Expense	628	778	904	1,110	1,334	1,609	2,225	2,757	3,397	3,762
Amortization Expense	-	-	-	0.07	0.03	5.16	8.78	8.75	5.01	2.74
Other Special Charges / (Income)	-	-	-	-	-	-	0.00	-10	0.00	0.00
Total Other Income / (Expense), net	-0.58	1.58	4.00	9.41	8.28	-0.64	0.51	4.16	43	70
Other Income / (Expense), net	-0.58	1.58	4.00	9.41	8.28	-0.64	0.51	4.16	43	70
Income Tax Expense	102	119	201	231	252	230	359	478	626	761
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)	-	-	-	-	-	-	47	122	35	160
Basic Earnings per Share	$1.90	$2.21	$1.90	$3.63	$4.95	$4.52	$7.52	$6.70	$12.23	$14.67
Weighted Average Basic Shares Outstanding	140.37M	137.09M	135.99M	133.41M	130.39M	130.29M	129.77M	127.67M	126.73M	123.74M
Diluted Earnings per Share	$1.89	$2.21	$1.90	$3.61	$4.93	$4.50	$7.49	$6.68	$12.20	$14.64
Weighted Average Diluted Shares Outstanding	140.61M	137.30M	136.20M	133.97M	130.96M	130.87M	130.30M	128.02M	127.06M	123.94M
Weighted Average Basic & Diluted Shares Outstanding	140M	137.30M	136.10M	133.30M	124.12M	125.16M	122.71M	122.05M	120.89M	115.52M

This table shows Lululemon Athletica's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Income / (Loss) Attributable to Common Shareholders	176	159	265	379	173	721	291	378	342	644
Consolidated Net Income / (Loss)	255	120	290	342	249	669	321	393	352	748
Net Income / (Loss) Continuing Operations	255	120	290	342	249	669	321	393	352	748
Total Pre-Tax Income	353	318	409	487	348	932	456	558	504	1,058
Total Operating Income	352	314	401	479	338	914	433	540	491	1,042
Total Gross Profit	1,039	1,528	1,151	1,299	1,257	1,903	1,275	1,412	1,402	2,182
Total Revenue	1,857	2,772	2,001	2,209	2,204	3,205	2,209	2,371	2,397	3,611
Operating Revenue	1,857	2,772	2,001	2,209	2,204	3,205	2,209	2,371	2,397	3,611
Total Cost of Revenue	818	1,244	850	911	948	1,302	934	959	995	1,430
Operating Cost of Revenue	818	1,244	850	911	948	1,302	934	959	995	1,430
Total Operating Expenses	686	1,213	749	819	919	990	842	872	911	1,140
Selling, General & Admin Expense	684	803	748	817	843	990	842	872	910	1,138
Amortization Expense	2.19	2.17	1.88	1.88	1.25	-	0.00	0.00	1.12	1.62
Total Other Income / (Expense), net	0.33	3.71	8.03	7.36	9.84	18	23	18	14	15
Other Income / (Expense), net	0.33	3.71	8.03	7.36	9.84	18	23	18	14	15
Income Tax Expense	97	198	119	145	99	262	135	165	153	309
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)	80	26	25	-38	76	-28	31	15	9.99	105
Basic Earnings per Share	$2.00	$0.95	$2.28	$2.69	$1.97	$5.29	$2.55	$3.15	$2.87	$6.10
Weighted Average Basic Shares Outstanding	127.51M	127.67M	127.25M	126.97M	126.46M	126.73M	125.99M	124.72M	122.70M	123.74M
Diluted Earnings per Share	$2.00	$0.94	$2.28	$2.68	$1.96	$5.28	$2.54	$3.15	$2.87	$6.08
Weighted Average Diluted Shares Outstanding	127.82M	128.02M	127.62M	127.26M	126.77M	127.06M	126.34M	124.86M	122.80M	123.94M
Weighted Average Basic & Diluted Shares Outstanding	122.40M	122.05M	121.95M	121.43M	121.07M	120.89M	119.89M	117.66M	116.67M	115.52M

This table details how cash moves in and out of Lululemon Athletica's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Change in Cash & Equivalents	-163	233	256	-109	212	57	109	-105	1,089	-260
Net Cash From Operating Activities	298	386	489	743	669	803	1,389	966	2,296	2,273
Net Cash From Continuing Operating Activities	298	386	489	743	669	803	1,389	966	2,296	2,273
Net Income / (Loss) Continuing Operations	266	303	259	484	646	589	975	855	1,550	1,815
Consolidated Net Income / (Loss)	266	303	259	484	646	589	975	855	1,550	1,815
Depreciation Expense	73	88	108	122	162	185	224	292	379	447
Non-Cash Adjustments To Reconcile Net Income	6.71	12	29	6.83	49	42	79	501	233	6.02
Changes in Operating Assets and Liabilities, net	-49	-17	93	130	-187	-13	110	-681	133	5.56
Net Cash From Investing Activities	-143	-150	-173	-243	-278	-696	-428	-570	-654	-798
Net Cash From Continuing Investing Activities	-143	-150	-173	-243	-278	-696	-428	-570	-654	-798
Purchase of Property, Plant & Equipment	-143	-150	-158	-226	-283	-229	-395	-639	-652	-689
Acquisitions	-	-	-	0.00	0.00	-453	-	-	-	-154
Purchase of Investments	0.00	0.00	-7.20	-16	0.35	-15	-23	-	-1.61	50
Other Investing Activities, net	0.00	0.00	-8.33	-0.77	4.29	0.88	-10	21	-0.66	-5.01
Net Cash From Financing Activities	-272	-27	-98	-590	-177	-81	-845	-467	-549	-1,653
Net Cash From Continuing Financing Activities	-272	-27	-98	-590	-177	-81	-845	-467	-549	-1,653
Repayment of Debt	0.00	-0.92	0.00	-0.75	0.00	0.00	-0.77	-0.03	-0.03	-0.03
Repurchase of Common Equity	-274	-29	-100	-598	-173	-64	-813	-444	-559	-1,637
Issuance of Common Equity	4.70	6.91	5.63	18	18	15	18	12	42	20
Other Financing Activities, net	-2.86	-3.27	-3.23	-8.78	-22	-32	-50	-35	-33	-35
Effect of Exchange Rate Changes	-45	23	-	-19	-1.55	30	-6.88	-34	-	-82

This table details how cash moves in and out of Lululemon Athletica's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Change in Cash & Equivalents	-146	802	-204	157	-16	1,153	-343	-291	-422	796
Net Cash From Operating Activities	66	1,046	46	477	390	1,384	128	443	301	1,401
Net Cash From Continuing Operating Activities	66	1,046	46	477	390	1,384	128	443	301	1,401
Net Income / (Loss) Continuing Operations	255	120	290	342	249	669	321	393	352	748
Consolidated Net Income / (Loss)	255	120	290	342	249	669	321	393	352	748
Depreciation Expense	79	80	84	94	98	103	96	104	114	134
Non-Cash Adjustments To Reconcile Net Income	16	455	21	58	139	35	27	7.97	34	-62
Changes in Operating Assets and Liabilities, net	-285	391	-350	-17	-96	576	-316	-61	-198	581
Net Cash From Investing Activities	-162	-183	-138	-145	-162	-209	-132	-135	-309	-223
Net Cash From Continuing Investing Activities	-162	-183	-138	-145	-162	-209	-132	-135	-309	-223
Purchase of Property, Plant & Equipment	-176	-207	-137	-146	-163	-207	-131	-145	-178	-235
Acquisitions	-	-	-	-	-	-	-	-	-	-23
Net Cash From Financing Activities	-15	-68	-115	-190	-205	-38	-329	-588	-412	-324
Net Cash From Continuing Financing Activities	-15	-68	-115	-190	-205	-38	-329	-588	-412	-324
Repurchase of Common Equity	-17	-69	-98	-194	-213	-54	-299	-589	-413	-335
Issuance of Common Equity	4.06	1.46	12	4.23	8.84	17	3.39	2.37	1.51	13
Other Financing Activities, net	-1.92	-0.46	-29	-0.94	-1.14	-1.70	-33	-0.83	-0.89	-1.15
Effect of Exchange Rate Changes	-	7.11	3.86	-	-	-	-11	-11	-1.80	-59

This table presents Lululemon Athletica's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total Assets	1,314	1,658	1,998	2,085	3,281	4,185	4,942	5,607	7,092	7,603
Total Current Assets	917	1,163	1,436	1,429	1,808	2,124	2,615	3,159	4,061	3,980
Cash & Equivalents	501	735	991	881	1,094	1,151	1,260	1,155	2,244	1,984
Accounts Receivable	13	9.20	19	36	40	62	77	133	125	120
Inventories, net	284	298	330	405	519	647	966	1,447	1,324	1,442
Prepaid Expenses	27	39	48	58	71	125	193	239	185	251
Current Deferred & Refundable Income Taxes	91	81	49	49	85	139	119	186	184	182
Plant, Property, & Equipment, net	350	423	474	567	0.00	746	928	1,270	1,546	1,781
Total Noncurrent Assets	47	71	89	88	1,473	1,315	1,400	1,178	1,486	1,842
Goodwill	25	25	25	24	24	387	387	24	24	160
Intangible Assets	-	-	-	-	0.24	80	71	22	0.00	12
Noncurrent Deferred & Refundable Income Taxes	12	26	32	27	31	6.73	6.09	6.40	9.18	17
Other Noncurrent Operating Assets	11	20	31	37	1,418	841	936	1,125	1,452	1,654
Total Liabilities & Shareholders' Equity	1,314	1,658	1,998	2,085	3,281	4,185	4,942	5,607	7,092	7,603
Total Liabilities	287	298	402	639	1,329	1,627	2,202	2,458	2,860	3,279
Total Current Liabilities	226	242	293	500	620	883	1,405	1,492	1,631	1,840
Accounts Payable	10	25	25	96	80	172	290	173	348	271
Accrued Expenses	134	132	182	228	239	383	539	399	655	868
Current Deferred & Payable Income Tax Liabilities	38	30	16	67	26	8.36	134	174	12	183
Current Employee Benefit Liabilities	44	55	70	109	134	130	205	248	326	205
Other Current Liabilities	-	0.00	-	-	141	190	238	498	290	313
Total Noncurrent Liabilities	61	56	109	138	709	743	797	966	1,229	1,440
Noncurrent Deferred Revenue	-	0.00	48	42	48	43	38	29	16	0.00
Noncurrent Deferred & Payable Income Tax Liabilities	11	7.26	1.34	14	43	59	53	55	30	98
Other Noncurrent Operating Liabilities	50	48	59	82	617	642	706	882	1,183	1,341
Commitments & Contingencies	-	-	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,027	1,360	1,597	1,446	1,952	2,559	2,740	3,149	4,232	4,324
Total Preferred & Common Equity	1,027	1,360	1,597	1,446	1,952	2,559	2,740	3,149	4,232	4,324
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	1,027	1,360	1,597	1,446	1,952	2,559	2,740	3,149	4,232	4,324
Common Stock	246	267	285	316	356	389	423	475	576	639
Retained Earnings	1,020	1,294	1,455	1,347	1,821	2,346	2,513	2,926	3,920	4,110
Accumulated Other Comprehensive Income / (Loss)	-238	-202	-143	-217	-225	-177	-196	-253	-264	-424
Other Equity Adjustments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

This table presents Lululemon Athletica's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024
Total Assets	5,309	5,607	5,572	5,992	6,022	7,092	6,828	6,744	7,084
Total Current Assets	2,634	3,159	3,053	3,324	3,365	4,061	3,768	3,572	3,605
Cash & Equivalents	353	1,155	951	1,108	1,091	2,244	1,901	1,610	1,188
Accounts Receivable	96	133	107	106	107	125	126	126	143
Inventories, net	1,742	1,447	1,580	1,661	1,664	1,324	1,345	1,429	1,801
Prepaid Expenses	247	239	233	225	203	185	203	195	215
Current Deferred & Refundable Income Taxes	196	186	182	225	300	184	193	211	257
Plant, Property, & Equipment, net	1,122	1,270	1,313	1,367	1,414	1,546	1,561	1,615	1,698
Total Noncurrent Assets	1,553	1,178	1,205	1,301	1,243	1,486	1,499	1,557	1,781
Goodwill	387	24	24	24	24	24	24	24	164
Intangible Assets	65	22	20	18	0.00	0.00	-	-	14
Noncurrent Deferred & Refundable Income Taxes	5.59	6.40	6.13	6.19	5.90	9.18	9.10	9.10	9.25
Other Noncurrent Operating Assets	1,096	1,125	1,155	1,253	1,214	1,452	1,466	1,524	1,593
Total Liabilities & Shareholders' Equity	5,309	5,607	5,572	5,992	6,022	7,092	6,828	6,744	7,084
Total Liabilities	2,270	2,458	2,251	2,459	2,496	2,860	2,609	2,712	3,098
Total Current Liabilities	1,323	1,492	1,257	1,386	1,448	1,631	1,384	1,469	1,804
Accounts Payable	301	173	287	299	309	348	262	317	386
Accrued Expenses	357	399	567	615	606	655	643	647	800
Current Deferred & Payable Income Tax Liabilities	81	174	30	21	27	12	53	19	97
Current Employee Benefit Liabilities	184	248	125	192	250	326	133	175	190
Other Current Liabilities	400	498	247	259	255	290	293	310	331
Total Noncurrent Liabilities	947	966	995	1,073	1,048	1,229	1,225	1,244	1,294
Noncurrent Deferred Revenue	29	29	29	16	16	16	16	0.00	0.00
Noncurrent Deferred & Payable Income Tax Liabilities	51	55	55	55	54	30	29	29	33
Other Noncurrent Operating Liabilities	868	882	912	1,001	979	1,183	1,180	1,215	1,261
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	3,039	3,149	3,320	3,533	3,526	4,232	4,220	4,032	3,986
Total Preferred & Common Equity	3,039	3,149	3,320	3,533	3,526	4,232	4,220	4,032	3,986
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	3,039	3,149	3,320	3,533	3,526	4,232	4,220	4,032	3,986
Common Stock	456	475	479	506	537	576	571	590	611
Retained Earnings	2,875	2,926	3,119	3,268	3,305	3,920	3,944	3,752	3,695
Accumulated Other Comprehensive Income / (Loss)	-292	-253	-278	-240	-316	-264	-295	-310	-320
Other Equity Adjustments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

This table displays calculated financial ratios and metrics derived from Lululemon Athletica's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	14.65%	13.78%	13.00%	24.13%	21.01%	10.62%	42.14%	29.63%	18.60%	10.07%
EBITDA Growth	0.09%	15.51%	11.33%	47.43%	26.45%	-5.14%	55.06%	4.25%	57.30%	18.30%
EBIT Growth	-3.82%	14.72%	8.82%	55.49%	25.47%	-8.70%	62.80%	-0.10%	63.27%	18.40%
NOPAT Growth	13.58%	13.43%	-15.16%	86.20%	33.97%	-7.86%	65.42%	-12.60%	78.32%	16.16%
Net Income Growth	11.30%	14.03%	-14.74%	87.04%	33.44%	-8.78%	65.61%	-12.36%	81.35%	17.06%
EPS Growth	13.86%	16.93%	-14.03%	90.00%	36.57%	-8.72%	66.44%	-10.81%	82.63%	20.00%
Operating Cash Flow Growth	-5.38%	29.86%	26.64%	51.79%	-9.89%	20.02%	72.92%	-30.43%	137.58%	-1.02%
Free Cash Flow Firm Growth	-20.23%	22.69%	35.43%	88.76%	-33.44%	-88.42%	2,155.13%	-62.52%	350.79%	-7.34%
Invested Capital Growth	23.74%	18.85%	-2.99%	-6.89%	52.08%	63.97%	5.12%	34.71%	-0.29%	17.69%
Revenue Q/Q Growth	5.20%	3.79%	5.53%	7.83%	6.14%	8.16%	6.82%	8.61%	4.72%	3.99%
EBITDA Q/Q Growth	2.91%	7.01%	12.71%	11.15%	10.02%	4.49%	10.15%	-13.55%	33.19%	5.45%
EBIT Q/Q Growth	2.30%	7.71%	15.01%	12.03%	10.37%	4.92%	11.14%	-16.98%	39.28%	5.13%
NOPAT Q/Q Growth	2.76%	6.63%	-5.92%	25.51%	14.27%	6.12%	11.93%	-27.11%	54.74%	4.81%
Net Income Q/Q Growth	2.53%	6.58%	-5.95%	25.63%	14.05%	5.71%	12.02%	-26.91%	54.94%	4.55%
EPS Q/Q Growth	2.72%	7.80%	-5.47%	26.67%	14.65%	5.88%	12.46%	-26.51%	55.22%	5.78%
Operating Cash Flow Q/Q Growth	71.44%	4.36%	16.78%	10.06%	28.47%	21.79%	0.95%	48.42%	17.25%	0.77%
Free Cash Flow Firm Q/Q Growth	203.88%	-5.91%	22.04%	15.78%	72.50%	163.16%	1.72%	129.69%	23.62%	6.96%
Invested Capital Q/Q Growth	-19.88%	-13.67%	-21.36%	-19.70%	-19.19%	-16.26%	-11.09%	-25.78%	-18.34%	-16.36%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	48.39%	51.17%	52.80%	55.23%	55.87%	55.98%	57.68%	55.39%	58.31%	59.22%
EBITDA Margin	21.44%	21.77%	21.45%	25.48%	26.62%	22.83%	24.90%	20.03%	26.56%	28.55%
Operating Margin	17.91%	17.96%	17.21%	21.46%	22.34%	18.63%	21.31%	16.38%	22.17%	23.67%
EBIT Margin	17.88%	18.03%	17.36%	21.75%	22.55%	18.61%	21.32%	16.43%	22.62%	24.33%
Profit (Net Income) Margin	12.91%	12.94%	9.76%	14.71%	16.22%	13.38%	15.59%	10.54%	16.12%	17.14%
Tax Burden Percent	72.20%	71.77%	56.23%	67.64%	71.94%	71.88%	73.12%	64.15%	71.25%	70.44%
Interest Burden Percent	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Effective Tax Rate	27.80%	28.23%	43.77%	32.36%	28.06%	28.12%	26.88%	35.85%	28.75%	29.56%
Return on Invested Capital (ROIC)	56.03%	52.51%	41.64%	81.53%	89.88%	52.00%	67.51%	49.06%	76.32%	81.57%
ROIC Less NNEP Spread (ROIC-NNEP)	56.11%	52.33%	41.38%	80.85%	89.27%	52.04%	67.48%	48.83%	74.51%	79.22%
Return on Net Nonoperating Assets (RNNOA)	-30.90%	-27.10%	-24.14%	-49.74%	-51.88%	-25.89%	-30.70%	-20.02%	-34.31%	-39.15%
Return on Equity (ROE)	25.13%	25.41%	17.50%	31.80%	38.00%	26.11%	36.81%	29.03%	42.01%	42.42%
Cash Return on Invested Capital (CROIC)	34.81%	35.29%	44.67%	88.67%	48.56%	3.53%	62.52%	19.48%	76.61%	65.32%
Operating Return on Assets (OROA)	28.23%	28.45%	25.16%	35.03%	33.45%	21.95%	29.23%	25.26%	34.27%	35.06%
Return on Assets (ROA)	20.38%	20.42%	14.15%	23.70%	24.06%	15.77%	21.37%	16.21%	24.41%	24.70%
Return on Common Equity (ROCE)	25.13%	25.41%	17.50%	31.80%	38.00%	26.11%	36.81%	29.03%	42.01%	42.42%
Return on Equity Simple (ROE_SIMPLE)	25.89%	22.31%	16.20%	33.46%	33.07%	23.02%	35.60%	27.15%	36.63%	41.97%
Net Operating Profit after Tax (NOPAT)	266	302	256	477	640	589	975	852	1,520	1,765
NOPAT Margin	12.93%	12.89%	9.68%	14.52%	16.07%	13.39%	15.58%	10.51%	15.80%	16.67%
Net Nonoperating Expense Percent (NNEP)	-0.07%	0.18%	0.26%	0.68%	0.60%	-0.04%	0.03%	0.22%	1.81%	2.35%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-	-	40.82%
Cost of Revenue to Revenue	51.61%	48.83%	47.20%	44.77%	44.13%	44.02%	42.32%	44.61%	41.69%	40.78%
SG&A Expenses to Revenue	30.48%	33.21%	34.13%	33.77%	33.53%	36.55%	35.56%	34.00%	35.32%	35.53%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	30.48%	33.21%	35.59%	33.77%	33.53%	37.35%	36.36%	39.01%	36.14%	35.56%
Earnings before Interest and Taxes (EBIT)	368	423	460	715	897	819	1,334	1,333	2,176	2,576
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	442	510	568	838	1,059	1,005	1,558	1,624	2,555	3,023
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	7.78	6.25	6.22	12.39	15.12	16.07	14.31	12.08	13.68	11.18
Price to Tangible Book Value (P/TBV)	7.97	6.37	6.32	12.60	15.32	19.66	17.18	12.26	13.75	11.64
Price to Revenue (P/Rev)	3.88	3.63	3.75	5.45	7.42	9.34	6.27	4.69	6.02	4.56
Price to Earnings (P/E)	30.04	28.04	38.40	37.04	45.73	69.83	40.98	47.67	37.62	29.21
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	3.33%	3.57%	2.60%	2.70%	2.19%	1.43%	2.44%	2.10%	2.66%	3.42%
Enterprise Value to Invested Capital (EV/IC)	14.24	12.43	14.74	30.17	33.11	28.39	25.63	18.50	27.98	19.81
Enterprise Value to Revenue (EV/Rev)	3.64	3.31	3.38	5.18	7.14	9.08	6.06	4.55	5.78	4.38
Enterprise Value to EBITDA (EV/EBITDA)	16.95	15.22	15.74	20.34	26.84	39.78	24.35	22.71	21.77	15.33
Enterprise Value to EBIT (EV/EBIT)	20.33	18.38	19.44	23.82	31.68	48.79	28.44	27.69	25.57	17.99
Enterprise Value to NOPAT (EV/NOPAT)	28.11	25.71	34.87	35.68	44.45	67.83	38.92	43.29	36.61	26.25
Enterprise Value to Operating Cash Flow (EV/OCF)	25.17	20.11	18.27	22.94	42.48	49.76	27.31	38.17	24.23	20.39
Enterprise Value to Free Cash Flow (EV/FCFF)	45.24	38.26	32.51	32.81	82.27	998.52	42.03	109.03	36.47	32.78
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.55	-0.52	-0.58	-0.62	-0.58	-0.50	-0.45	-0.41	-0.46	-0.49
Leverage Ratio	1.23	1.24	1.24	1.34	1.58	1.66	1.72	1.79	1.72	1.72
Compound Leverage Factor	1.23	1.24	1.24	1.34	1.58	1.66	1.72	1.79	1.72	1.72
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	20.94	21.17	18.63	20.98	16.65	18.01	13.84	12.60	15.70	12.45
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	4.07	4.80	4.91	2.86	2.91	2.41	1.86	2.12	2.49	2.16
Quick Ratio	2.28	3.07	3.45	1.83	1.83	1.37	0.95	0.86	1.45	1.14
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	166	203	275	519	346	40	903	338	1,525	1,413
Operating Cash Flow to CapEx	207.36%	258.44%	309.97%	328.94%	236.47%	350.46%	352.12%	151.33%	352.25%	329.75%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.58	1.58	1.45	1.61	1.48	1.18	1.37	1.54	1.52	1.44
Accounts Receivable Turnover	153.46	210.18	186.74	119.66	104.71	85.79	89.76	77.28	74.66	86.45
Inventory Turnover	4.32	3.93	3.98	4.01	3.80	3.32	3.28	3.00	2.89	3.12
Fixed Asset Turnover	6.38	6.06	5.91	6.32	0.00	0.00	7.48	7.38	6.83	6.37
Accounts Payable Turnover	107.85	64.99	50.53	24.50	20.01	15.37	11.46	15.65	15.39	13.93
Days Sales Outstanding (DSO)	2.38	1.74	1.95	3.05	3.49	4.25	4.07	4.72	4.89	4.22
Days Inventory Outstanding (DIO)	84.46	92.85	91.66	91.05	95.97	109.78	111.21	121.75	126.11	116.91
Days Payable Outstanding (DPO)	3.38	5.62	7.22	14.90	18.24	23.75	31.84	23.33	23.72	26.20
Cash Conversion Cycle (CCC)	83.46	88.97	86.39	79.20	81.21	90.28	83.44	103.15	107.28	94.93
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	526	625	606	565	859	1,408	1,480	1,994	1,988	2,340
Invested Capital Turnover	4.33	4.07	4.30	5.62	5.59	3.88	4.33	4.67	4.83	4.89
Increase / (Decrease) in Invested Capital	101	99	-19	-42	294	549	72	514	-5.82	352
Enterprise Value (EV)	7,490	7,771	8,942	17,037	28,432	39,975	37,942	36,893	55,633	46,339
Market Capitalization	7,991	8,506	9,932	17,918	29,525	41,125	39,202	38,048	57,877	48,324
Book Value per Share	$7.98	$10.68	$12.71	$11.79	$15.83	$20.45	$22.08	$25.73	$34.95	$37.06
Tangible Book Value per Share	$7.79	$10.49	$12.52	$11.59	$15.63	$16.72	$18.39	$25.35	$34.76	$35.60
Total Capital	1,027	1,360	1,597	1,446	1,952	2,559	2,740	3,149	4,232	4,324
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-501	-735	-991	-881	-1,094	-1,151	-1,260	-1,155	-2,244	-1,984
Capital Expenditures (CapEx)	143	150	158	226	283	229	395	639	652	689
Debt-free, Cash-free Net Working Capital (DFCFNWC)	190	186	153	47	94	91	-50	512	185	156
Debt-free Net Working Capital (DFNWC)	692	921	1,144	929	1,188	1,241	1,210	1,667	2,429	2,141
Net Working Capital (NWC)	692	921	1,144	929	1,188	1,241	1,210	1,667	2,429	2,141
Net Nonoperating Expense (NNE)	0.42	-1.13	-2.25	-6.37	-5.96	0.46	-0.38	-2.67	-31	-50
Net Nonoperating Obligations (NNO)	-501	-735	-991	-881	-1,094	-1,151	-1,260	-1,155	-2,244	-1,984
Total Depreciation and Amortization (D&A)	73	88	108	122	162	185	224	292	379	447
Debt-free, Cash-free Net Working Capital to Revenue	9.22%	7.93%	5.78%	1.44%	2.36%	2.06%	-0.80%	6.32%	1.93%	1.48%
Debt-free Net Working Capital to Revenue	33.56%	39.27%	43.17%	28.25%	29.84%	28.20%	19.33%	20.56%	25.25%	20.22%
Net Working Capital to Revenue	33.56%	39.27%	43.17%	28.25%	29.84%	28.20%	19.33%	20.56%	25.25%	20.22%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.90	$2.21	$1.90	$3.63	$4.95	$4.52	$7.52	$6.70	$12.23	$14.67
Adjusted Weighted Average Basic Shares Outstanding	140.37M	137.09M	135.99M	133.41M	130.39M	130.29M	129.77M	127.67M	126.73M	123.74M
Adjusted Diluted Earnings per Share	$1.89	$2.21	$1.90	$3.61	$4.93	$4.50	$7.49	$6.68	$12.20	$14.64
Adjusted Weighted Average Diluted Shares Outstanding	140.61M	137.30M	136.20M	133.97M	130.96M	130.87M	130.30M	128.02M	127.06M	123.94M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	127.49M	127.27M	125.68M	123.28M	124.12M	125.16M	122.71M	122.05M	120.89M	115.52M
Normalized Net Operating Profit after Tax (NOPAT)	266	302	278	477	640	611	1,005	1,107	1,573	1,765
Normalized NOPAT Margin	12.93%	12.89%	10.50%	14.52%	16.07%	13.88%	16.07%	13.65%	16.35%	16.67%
Pre Tax Income Margin	17.88%	18.03%	17.36%	21.75%	22.55%	18.61%	21.32%	16.43%	22.62%	24.33%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	103.12%	9.67%	38.76%	123.67%	26.86%	10.81%	83.32%	51.94%	36.04%	90.21%

This table displays calculated financial ratios and metrics derived from Lululemon Athletica's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	28.02%	30.19%	24.01%	18.24%	18.70%	15.63%	10.40%	7.33%	8.73%	12.68%
EBITDA Growth	36.72%	-38.99%	51.96%	23.72%	3.24%	159.86%	11.78%	13.98%	38.59%	15.08%
EBIT Growth	36.75%	-46.15%	57.28%	21.24%	-1.36%	192.87%	11.35%	14.71%	44.96%	13.50%
NOPAT Growth	35.92%	-72.74%	49.84%	16.25%	-5.31%	454.54%	7.13%	13.03%	41.63%	12.32%
Net Income Growth	36.04%	-72.43%	52.85%	17.99%	-2.64%	458.77%	10.68%	15.02%	41.48%	11.79%
EPS Growth	38.89%	-71.94%	54.05%	18.58%	-2.00%	461.70%	11.40%	17.54%	46.43%	15.15%
Operating Cash Flow Growth	-58.44%	43.13%	118.71%	388.24%	492.33%	32.29%	180.25%	-7.04%	-22.88%	1.25%
Free Cash Flow Firm Growth	-475.20%	-209.14%	82.18%	147.40%	164.39%	267.57%	640.67%	42.76%	-104.12%	-41.74%
Invested Capital Growth	61.37%	34.71%	17.36%	2.84%	-9.38%	-0.29%	-2.12%	-0.18%	14.89%	17.69%
Revenue Q/Q Growth	-0.61%	49.27%	-27.82%	10.41%	-0.22%	45.41%	-31.08%	7.34%	1.08%	50.69%
EBITDA Q/Q Growth	-7.96%	-7.79%	23.92%	17.64%	-23.20%	132.10%	-46.70%	19.96%	-6.62%	92.74%
EBIT Q/Q Growth	-12.11%	-9.81%	28.70%	18.85%	-28.50%	167.77%	-51.07%	22.44%	-9.64%	109.66%
NOPAT Q/Q Growth	-11.81%	-53.61%	140.44%	18.17%	-28.16%	171.71%	-53.55%	24.67%	-9.99%	115.47%
Net Income Q/Q Growth	-11.76%	-53.10%	142.39%	17.63%	-27.19%	169.17%	-51.99%	22.25%	-10.45%	112.69%
EPS Q/Q Growth	-11.50%	-53.00%	142.55%	17.54%	-26.87%	169.39%	-51.89%	24.02%	-8.89%	111.85%
Operating Cash Flow Q/Q Growth	-32.59%	1,489.66%	-95.65%	947.65%	-18.22%	255.03%	-90.79%	247.50%	-32.15%	366.11%
Free Cash Flow Firm Q/Q Growth	-34.84%	48.42%	83.38%	509.98%	83.17%	34.23%	-46.36%	8.26%	-105.28%	1,999.36%
Invested Capital Q/Q Growth	13.89%	-25.78%	18.83%	2.38%	0.36%	-18.34%	16.65%	4.42%	15.52%	-16.36%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	55.95%	55.11%	57.52%	58.78%	57.01%	59.39%	57.72%	59.56%	58.48%	60.42%
EBITDA Margin	23.26%	14.37%	24.67%	26.28%	20.23%	32.29%	24.98%	27.91%	25.79%	32.98%
Operating Margin	18.98%	11.34%	20.06%	21.69%	15.34%	28.51%	19.59%	22.78%	20.47%	28.86%
EBIT Margin	19.00%	11.48%	20.46%	22.03%	15.79%	29.07%	20.64%	23.54%	21.05%	29.28%
Profit (Net Income) Margin	13.76%	4.32%	14.51%	15.46%	11.28%	20.89%	14.55%	16.57%	14.68%	20.72%
Tax Burden Percent	72.42%	37.66%	70.93%	70.20%	71.48%	71.85%	70.50%	70.39%	69.76%	70.77%
Interest Burden Percent	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Effective Tax Rate	27.58%	62.34%	29.07%	29.80%	28.52%	28.15%	29.50%	29.61%	30.24%	29.23%
Return on Invested Capital (ROIC)	47.18%	19.95%	55.11%	56.26%	39.33%	98.98%	57.88%	66.10%	55.59%	99.92%
ROIC Less NNEP Spread (ROIC-NNEP)	47.14%	19.83%	54.40%	55.62%	38.36%	98.23%	56.73%	65.16%	54.74%	99.41%
Return on Net Nonoperating Assets (RNNOA)	-11.14%	-8.13%	-14.53%	-13.98%	-8.44%	-45.23%	-21.45%	-23.41%	-16.61%	-49.13%
Return on Equity (ROE)	36.04%	11.81%	40.58%	42.28%	30.90%	53.75%	36.43%	42.69%	38.97%	50.80%
Cash Return on Invested Capital (CROIC)	6.77%	19.48%	27.20%	38.78%	48.19%	76.61%	67.83%	65.51%	50.51%	65.32%
Operating Return on Assets (OROA)	28.71%	17.65%	33.87%	35.68%	25.59%	44.04%	32.72%	36.93%	32.70%	42.20%
Return on Assets (ROA)	20.79%	6.65%	24.02%	25.05%	18.29%	31.64%	23.06%	25.99%	22.81%	29.86%
Return on Common Equity (ROCE)	36.04%	11.81%	40.58%	42.28%	30.90%	53.75%	36.43%	42.69%	38.97%	50.80%
Return on Equity Simple (ROE_SIMPLE)	38.48%	0.00%	28.77%	28.51%	28.38%	0.00%	37.47%	40.49%	43.55%	0.00%
Net Operating Profit after Tax (NOPAT)	255	118	285	336	242	657	305	380	342	738
NOPAT Margin	13.75%	4.27%	14.23%	15.23%	10.96%	20.49%	13.81%	16.04%	14.28%	20.42%
Net Nonoperating Expense Percent (NNEP)	0.04%	0.12%	0.71%	0.64%	0.97%	0.75%	1.15%	0.93%	0.84%	0.51%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-	-	17.06%
Cost of Revenue to Revenue	44.05%	44.89%	42.48%	41.22%	42.99%	40.61%	42.28%	40.44%	41.52%	39.58%
SG&A Expenses to Revenue	36.85%	28.97%	37.36%	37.00%	38.24%	30.87%	38.14%	36.77%	37.96%	31.52%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	36.97%	43.77%	37.45%	37.08%	41.67%	30.87%	38.14%	36.77%	38.01%	31.56%
Earnings before Interest and Taxes (EBIT)	353	318	409	487	348	932	456	558	504	1,058
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	432	398	494	581	446	1,035	552	662	618	1,191
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	13.22	12.08	13.97	13.04	13.32	13.68	10.45	7.54	8.98	11.18
Price to Tangible Book Value (P/TBV)	15.52	12.26	14.15	13.20	13.41	13.75	10.51	7.58	9.40	11.64
Price to Revenue (P/Rev)	5.38	4.69	5.46	5.21	5.11	6.02	4.49	3.04	3.51	4.56
Price to Earnings (P/E)	38.09	47.67	51.85	47.05	48.10	37.62	28.19	19.45	20.67	29.21
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	2.63%	2.10%	1.93%	2.13%	2.08%	2.66%	3.55%	5.14%	4.84%	3.42%
Enterprise Value to Invested Capital (EV/IC)	14.82	18.50	19.17	18.54	18.84	27.98	18.19	11.89	12.37	19.81
Enterprise Value to Revenue (EV/Rev)	5.33	4.55	5.34	5.09	4.99	5.78	4.29	2.88	3.40	4.38
Enterprise Value to EBITDA (EV/EBITDA)	21.19	22.71	25.33	23.62	23.92	21.77	16.14	10.68	12.07	15.33
Enterprise Value to EBIT (EV/EBIT)	24.81	27.69	30.65	28.71	29.37	25.57	18.98	12.55	14.12	17.99
Enterprise Value to NOPAT (EV/NOPAT)	34.06	43.29	47.94	45.22	46.72	36.61	27.40	18.18	20.54	26.25
Enterprise Value to Operating Cash Flow (EV/OCF)	61.15	38.17	36.18	27.53	23.43	24.23	17.74	12.28	15.34	20.39
Enterprise Value to Free Cash Flow (EV/FCFF)	270.31	109.03	76.09	48.48	37.18	36.47	26.53	18.13	26.18	32.78
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.24	-0.41	-0.27	-0.25	-0.22	-0.46	-0.38	-0.36	-0.30	-0.49
Leverage Ratio	1.73	1.79	1.71	1.71	1.73	1.72	1.64	1.68	1.74	1.72
Compound Leverage Factor	1.73	1.79	1.71	1.71	1.73	1.72	1.64	1.68	1.74	1.72
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	13.30	12.01	15.30	14.14	14.16	15.12	13.03	9.63	9.64	11.79
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.99	2.12	2.43	2.40	2.32	2.49	2.72	2.43	2.00	2.16
Quick Ratio	0.34	0.86	0.84	0.88	0.83	1.45	1.47	1.18	0.74	1.14
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-766	-395	-66	269	494	662	355	385	-20	386
Operating Cash Flow to CapEx	37.48%	505.49%	33.23%	327.61%	239.32%	670.23%	97.58%	305.43%	168.45%	596.38%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.51	1.54	1.66	1.62	1.62	1.52	1.59	1.57	1.55	1.44
Accounts Receivable Turnover	87.08	77.28	91.44	94.03	90.42	74.66	84.06	85.99	81.32	86.45
Inventory Turnover	2.43	3.00	2.61	2.45	2.32	2.89	2.80	2.68	2.42	3.12
Fixed Asset Turnover	7.47	7.38	7.43	7.28	7.24	6.83	6.84	6.70	6.54	6.37
Accounts Payable Turnover	12.38	15.65	12.51	13.68	12.95	15.39	14.91	13.44	12.05	13.93
Days Sales Outstanding (DSO)	4.19	4.72	3.99	3.88	4.04	4.89	4.34	4.24	4.49	4.22
Days Inventory Outstanding (DIO)	150.03	121.75	139.89	149.08	157.24	126.11	130.42	136.14	150.92	116.91
Days Payable Outstanding (DPO)	29.49	23.33	29.18	26.68	28.18	23.72	24.48	27.15	30.29	26.20
Cash Conversion Cycle (CCC)	124.73	103.15	114.70	126.28	133.10	107.28	110.29	113.23	125.12	94.93
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	2,687	1,994	2,369	2,426	2,435	1,988	2,319	2,422	2,797	2,340
Invested Capital Turnover	3.43	4.67	3.87	3.69	3.59	4.83	4.19	4.12	3.89	4.89
Increase / (Decrease) in Invested Capital	1,022	514	350	67	-252	-5.82	-50	-4.42	363	352
Enterprise Value (EV)	39,822	36,893	45,419	44,984	45,879	55,633	42,189	28,781	34,598	46,339
Market Capitalization	40,174	38,048	46,370	46,092	46,970	57,877	44,089	30,391	35,786	48,324
Book Value per Share	$24.85	$25.73	$27.20	$28.98	$29.04	$34.95	$34.91	$33.63	$33.87	$37.06
Tangible Book Value per Share	$21.16	$25.35	$26.84	$28.63	$28.84	$34.76	$34.71	$33.43	$32.36	$35.60
Total Capital	3,039	3,149	3,320	3,533	3,526	4,232	4,220	4,032	3,986	4,324
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-353	-1,155	-951	-1,108	-1,091	-2,244	-1,901	-1,610	-1,188	-1,984
Capital Expenditures (CapEx)	176	207	137	146	163	207	131	145	178	235
Debt-free, Cash-free Net Working Capital (DFCFNWC)	959	512	846	830	826	185	484	493	613	156
Debt-free Net Working Capital (DFNWC)	1,311	1,667	1,797	1,938	1,917	2,429	2,385	2,103	1,802	2,141
Net Working Capital (NWC)	1,311	1,667	1,797	1,938	1,917	2,429	2,385	2,103	1,802	2,141
Net Nonoperating Expense (NNE)	-0.24	-1.40	-5.69	-5.17	-7.03	-13	-16	-13	-9.59	-11
Net Nonoperating Obligations (NNO)	-353	-1,155	-951	-1,108	-1,091	-2,244	-1,901	-1,610	-1,188	-1,984
Total Depreciation and Amortization (D&A)	79	80	84	94	98	103	96	104	114	134
Debt-free, Cash-free Net Working Capital to Revenue	12.84%	6.32%	9.95%	9.39%	8.99%	1.93%	4.92%	4.94%	6.02%	1.48%
Debt-free Net Working Capital to Revenue	17.56%	20.56%	21.14%	21.92%	20.87%	25.25%	24.26%	21.05%	17.70%	20.22%
Net Working Capital to Revenue	17.56%	20.56%	21.14%	21.92%	20.87%	25.25%	24.26%	21.05%	17.70%	20.22%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$2.00	$0.95	$2.28	$2.69	$1.97	$5.29	$2.55	$3.15	$2.87	$6.10
Adjusted Weighted Average Basic Shares Outstanding	127.51M	127.67M	127.25M	126.97M	126.46M	126.73M	125.99M	124.72M	122.70M	123.74M
Adjusted Diluted Earnings per Share	$2.00	$0.94	$2.28	$2.68	$1.96	$5.28	$2.54	$3.15	$2.87	$6.08
Adjusted Weighted Average Diluted Shares Outstanding	127.82M	128.02M	127.62M	127.26M	126.77M	127.06M	126.34M	124.86M	122.80M	123.94M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	122.40M	122.05M	121.95M	121.43M	121.07M	120.89M	119.89M	117.66M	116.67M	115.52M
Normalized Net Operating Profit after Tax (NOPAT)	255	220	285	336	295	657	305	380	342	738
Normalized NOPAT Margin	13.75%	7.94%	14.23%	15.23%	13.38%	20.49%	13.81%	16.04%	14.28%	20.42%
Pre Tax Income Margin	19.00%	11.48%	20.46%	22.03%	15.79%	29.07%	20.64%	23.54%	21.05%	29.28%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	59.53%	51.94%	32.44%	37.53%	57.34%	36.04%	48.04%	70.78%	78.10%	90.21%

Frequently Asked Questions About Lululemon Athletica's Financials

When does Lululemon Athletica's financial year end?

According to the most recent income statement we have on file, Lululemon Athletica's fiscal year ends in February. Their fiscal year 2025 ended on February 2, 2025.

How has Lululemon Athletica's net income changed over the last 9 years?

Lululemon Athletica's net income appears to be on an upward trend, with a most recent value of $1.81 billion in 2024, rising from $266.05 million in 2015. The previous period was $1.55 billion in 2023.

What is Lululemon Athletica's operating income?

Lululemon Athletica's total operating income in 2024 was $2.51 billion, based on the following breakdown:

Total Gross Profit: $6.27 billion
Total Operating Expenses: $3.77 billion

How has Lululemon Athletica revenue changed over the last 9 years?

Over the last 9 years, Lululemon Athletica's total revenue changed from $2.06 billion in 2015 to $10.59 billion in 2024, a change of 413.9%.

How much debt does Lululemon Athletica have?

Lululemon Athletica's total liabilities were at $3.28 billion at the end of 2024, a 14.7% increase from 2023, and a 1,044.2% increase since 2015.

How much cash does Lululemon Athletica have?

In the past 9 years, Lululemon Athletica's cash and equivalents has ranged from $501.48 million in 2015 to $2.24 billion in 2023, and is currently $1.98 billion as of their latest financial filing in 2024.

How has Lululemon Athletica's book value per share changed over the last 9 years?

Over the last 9 years, Lululemon Athletica's book value per share changed from 7.98 in 2015 to 37.06 in 2024, a change of 364.4%.

Related Companies

This page (NASDAQ:LULU) was last updated on 4/30/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Lululemon Athletica (LULU) Financials

Frequently Asked Questions About Lululemon Athletica's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Lululemon Athletica (LULU) Financials

Annual Income Statements for Lululemon Athletica

Quarterly Income Statements for Lululemon Athletica

Annual Cash Flow Statements for Lululemon Athletica

Quarterly Cash Flow Statements for Lululemon Athletica

Annual Balance Sheets for Lululemon Athletica

Quarterly Balance Sheets for Lululemon Athletica

Annual Metrics and Ratios for Lululemon Athletica

Quarterly Metrics and Ratios for Lululemon Athletica

Frequently Asked Questions About Lululemon Athletica's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools